Cameron Bissett
DPhil student
At the University of Oxford I completed an undergraduate master’s degree in Biochemistry (Molecular and Cellular). In my final master’s year, I completed my dissertation project at the Jenner Institute, in the Outbreak and Emerging Pathogens lab supervised by Prof. Teresa Lambe. My research primarily involved the development and immunological assessment of adenoviral-vectored vaccines against both influenza virus and respiratory syncytial virus (RSV), with particular focus on the prospect of an immunogenic, bivalent vector against both aforementioned viruses. Additionally, I assessed intranasal vaccinations as a means of eliciting mucosal immunity. Such vaccines would be of particular benefit to younger and older population cohorts most vulnerable to RSV- and Influenza virus-related pathologies. Currently, I am an NDM DPhil student at the Jenner Institute continuing research within immunology, specifically on vaccine development against viral respiratory pathogens including SARS-CoV-2.
Recent publications
Heterologous mucosal vaccine boosting enhances mucosal and systemic immunity by distinct mechanisms.
Journal article
Bissett C. et al, (2026), The Journal of experimental medicine, 223
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 Beta (B.1.351) and other variants of concern in preclinical studies
Journal article
Spencer AJ. et al, (2021)
Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce robust immune responses in mice
Journal article
Spencer AJ. et al, (2021)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Journal article
van Doremalen N. et al, (2020), Nature, 586, 578 - 582
The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
Journal article
Sharpe HR. et al, (2020), Immunology, 160, 223 - 232